Facebook
Twitter
LinkedIn
ForwardPediatrics Research Week 2022
Research Week is an event that spotlights the scholarly work from the departments residents, fellows, faculty, researchers and staff. Through a mix of livestreamed lectures and interactive sessions, Research Week’s celebration of scholarship will be virtually available to the University of Wisconsin School of Medicine and Public Health community and anyone interested in the latest advances in pediatric research. Activities for the week include small group sessions with faculty and trainees to discuss QI projects, mentoring and cross departmental research, the distinguished Gerard B. Odell Lecture, a Faculty Research Forum, platform presentations, and an online poster session featuring the research of residents, fellows, faculty and staff.
Intended Audience
This activity is intended for physicians, nurses, advanced practice providers (PA/NP), researchers, staff, fellows, residents, and students conducting and/or participating in research within the Department of Pediatrics.
Learning Objectives
- Discuss mechanisms for promoting collaborative research in Pediatrics
- Identify best practices for developing Mentor and Mentee relationships to enhance and grow research projects across interprofessional disciplines
- Demonstrate how QI initiatives and research directly impacts health care disparities
- Collaborate with faculty, staff, and trainees across interprofessional disciplines to identify best practices in research
Monday, May 23All times listed are Central Daylight Time (CDT) | |
| Morning Report, Quality Improvement & Scholarly Work (Online) | |
| 8:00 AM - 9:00 AM | QI and Scholarly Work (Mala Mathur, MD & Nina Menda, MD) |
| Afternoon Session | |
| *12:00 PM - 1:00 PM | MOC Part IV (Barbara Anderson, MS) |
*no credit offered for this session
Tuesday, May 24All times listed are Central Daylight Time (CDT) | |
| Morning Report, Mentor & Mentee Relationships (Online) | |
| 8:00 AM - 9:00 AM | Mentor Mentee Relationships (Megan Moreno, MD & Jesse Boyett Anderson, MD) |
| Afternoon Sessions (Online) | |
| 1:30 PM - 1:35 PM | Fellow Presentations Introduction |
| 1:35 PM - 1:55 PM | Heart rate variability, hypoxic-ischemic encephalopathy, and neurodevelopmental outcome: is there an association? (Megan Derrer, MD) |
| 1:55 PM - 2:15 PM | Improvements in accuracy and confidence in arrhythmia identification after cardiac surgery using the Atriamp signals (Diane Brown, MD) |
| 2:15 PM - 2:35 PM | New Insights into Factor IX Regulation (Christina Amend, MD) |
| 2:35 PM - 2:55 PM | The Interaction Between Small Airway Dysfunction, Allergic Sensitization, and Wheezing Illnesses: Updates from the URECA Birth Cohort (Vinay Goswamy, MD) |
| 2:55 PM - 3:15 PM | Symptom Adverse Events and Quality of Life of Children with Advanced Cancer: Results from a Longitudinal Study using the Pediatric Patient-Reported Outcomes-Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE) (Krista Grinde, DO) |
| 3:15 PM - 3:35 PM | Break |
| 3:35 PM - 3:55 PM | Factors Mediating Pediatric Provider Wellness Prior to and During the COVID-19 Pandemic: A Qualitative, Secondary Analysis of Survey Results. (Fatima Naqvi, MD) |
| 3:55 PM - 4:15 PM | Intra-operative renal NIRS monitoring of neonates undergoing cardiac surgery and the association with acute kidney injury (Dan Gorski, MD) |
| 4:15 PM - 4:35 PM | Feasibility of Near-Infrared Spectroscopy (NIRS) multi-sites regional oxygenation monitoring during primary intubation in the OR (Ting-Chang Hsieh, MD) |
| 4:35 PM - 4:55 PM | Transgender and Gender-Diverse Youth Have Higher Prevalence of Certain Autoimmune Diseases (Santhi Logel, MD) |
Wednesday, May 25All times listed are Central Daylight Time (CDT) | |
| Morning Report, WARF* | |
| *8:00 AM - 9:00 AM | WARF Presentation (Stephanie Whitehorse & Nicholas Von Bergen, MD) |
| Afternoon Session | |
| 12:00 PM - 1:00 PM | IDEAAs for Success: Tips and Tricks for Human Subjects Research (Elena Alfaro, MD) |
*no credit offered for this session
Thursday, May 26All times listed are Central Daylight Time (CDT) | |
| Odell Lecture/Peds Grand Rounds | |
| *7:30 AM - 8:30 AM Credit offered separately for this session | Susan Lynch, PhD |
| Odell Award Recipient Presentation | |
| 8:30 AM - 9:00 AM | Anne Marie Singh, MD |
| Wald Award Recipient Presentation | |
| 9:00 AM - 9:30 AM | Michelle Kelly, MD |
10:00-10:05 | Welcome Jim Gern, MD |
10:05-10:25 | Relationships between Early Exposures and Childhood Rhinitis Trajectories in an Early Life Birth Cohort Sima Ramratnam, MD |
10:25-10:45 | Innovative clinical trial design to improve the treatment of tuberculosis in children. Tony Garcia-Prats, MD |
10:45-11:05 | Hypovitaminosis and Vitamin C Deficiency in Critically Ill Pediatric Patients Undergoing Cardiopulmonary Bypass Awni Al-Subu, MD |
11:05-11:15 | 10 Minute Break |
11:15-11:35 | A pediatrician driven approach to understanding the physician well-being construct Sarah Webber, MD |
11:35-11:55 | E-cigarettes: Addressing Research Priorities as Use Rapidly EvolvesBrian Williams, MD |
11:55-12:25 | Updates from the Research Administration Team Becky Bound |
Friday, May 27All times listed are Central Daylight Time (CDT) | |
| 1:00 PM - 1:30 PM | Research Week Keynote Presentation |
| Ellen Wald, MD | |
| Platform Presentations | |
| 1:30 PM - 1:45 PM | Reducing time to enteral feeding during HFNC use for bronchiolitis (Hannah Schumacher, MD & Tyler Sternhagen, MD) |
| 1:45 PM - 2:00 PM | Sharp Rise in New-Onset Pediatric Diabetes During the Covid-19 Pandemic (Aisha Ansar, MBBS) |
| 2:00 PM - 2:15 PM | Atopic phenotype is influenced by biological sex and iron deficiency at birth (Narmin Mukhtarova, MD) |
| 2:15 PM - 2:30 PM | Improvements in post-operative cardiac surgery arrhythmia identification using the Atriamp signals (Diane Brown, MD) |
| 2:30 PM - 2:45 PM | Improved Insurance Coverage of Exome Sequencing in an Outpatient Medical Genetics Clinic Leads to Increases in Diagnoses and Positively Impacts Clinical Management (April Hall, PhD, MS, CGC) |
| 2:45 PM - 3:00 PM | Delivering Advancements in the Lives of Youth with Type 2 Diabetes (DAILY T2D): a quality improvement initiative to address disparities and provide quality, individualized care (Elizabeth Mann, MD) |
| 3:00 PM - 3:30 PM | Break & Viewing time for virtual posters and abstracts^ |
| 3:30 PM - 5:00 PM | Virtual Poster Session^ |
^Indicates session is not eligible for credit
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
| Jim Gern | Planner | MeissaVaccines Inc. (Independent Contractor - Consultant), AstraZeneca (Independent Contractor - Consultant) | No |
| Emily Ruedinger | Clinical Director, Planning Committee Chair | No relevant relationships with ineligible companies to disclose | No |
| Reva Finkelman | Planner | No relevant relationships with ineligible companies to disclose | No |
| Kate Dougherty | Planner | No relevant relationships with ineligible companies to disclose | No |
| Dan Sklansky | Planner | No relevant relationships with ineligible companies to disclose | No |
| Mala Mathur | Planner/Faculty | No relevant relationships with ineligible companies to disclose | No |
| Trish Barribeau | Planner | No relevant relationships with ineligible companies to disclose | No |
| Kim Stevenson | Planner | No relevant relationships with ineligible companies to disclose | No |
| Nina Menda | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Megan Moreno | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Jesse Boyett Anderson | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Megan Derrer | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Diane Brown | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Christina Amend | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Vinay Goswamy | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Krista Grinde | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Fatima Naqvi | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Dan Gorski | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Ting-Chang Hsieh | Faculty | No relevant relationships with ineligible companies to disclose | Yes |
| Santhi Logel | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Elena Alfaro | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Anne Marie Singh | Faculty | AbbVie, Inc. (Independent Contractor - Consultant), Siolta Therapeutics (Independent Contractor - Data And Safety Monitoring) | No |
| Michelle Kelly | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Sima Ramratnam | Faculty | SANOFI US SERVICES INC. (Independent Contractor - Consultant) | No |
| Tony Garcia-Prats | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Awni Al-Subu | Faculty | Edwards Lifesciences (Independent Contractor - Consultant) | No |
| Sarah Webber | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Brian Williams | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Rebecca Bound | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Hannah Schumacher | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Tyler Sternhagen | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Ellen Wald | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Aisha Ansar | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Narmin Mukhtarova | Faculty | No relevant relationships with ineligible companies to disclose | No |
| April Hall | Faculty | No relevant relationships with ineligible companies to disclose | No |
| Elizabeth Mann | Faculty | No relevant relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be commercial interests.
 | Accreditation Statement In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
American Medical Association (AMA) Continuing Education Units (CEUs) | |
Available Credit
- 11.25 AMA PRA Category 1 Credit™
- 11.25 University of Wisconsin–Madison Continuing Education Hours
- 11.25 Approved for AMA PRA Category 1 Credit™